GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Reshape Lifesciences Inc (STU:24O0) » Definitions » Accumulated other comprehensive income (loss)

Reshape Lifesciences (STU:24O0) Accumulated other comprehensive income (loss) : €-0.09 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Reshape Lifesciences Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Reshape Lifesciences's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2024 was €-0.09 Mil.

Reshape Lifesciences's quarterly Accumulated other comprehensive income (loss) increased from Sep. 2023 (€-0.09 Mil) to Dec. 2023 (€-0.08 Mil) but then declined from Dec. 2023 (€-0.08 Mil) to Mar. 2024 (€-0.09 Mil).

Reshape Lifesciences's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 (€-0.08 Mil) to Dec. 2022 (€-0.08 Mil) but then increased from Dec. 2022 (€-0.08 Mil) to Dec. 2023 (€-0.08 Mil).

Reshape Lifesciences Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Reshape Lifesciences's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Reshape Lifesciences Accumulated other comprehensive income (loss) Chart

Reshape Lifesciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 -0.10 -0.08 -0.08 -0.08

Reshape Lifesciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.09 -0.09 -0.09 -0.08 -0.09

Reshape Lifesciences Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Reshape Lifesciences Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Reshape Lifesciences's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Reshape Lifesciences (STU:24O0) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Reshape Lifesciences Inc (STU:24O0) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
NUWE FOMI NUMD VYCO OPGN HSCS VTAK THMO ODYY ADMT ABT SYK BSX MDT XTER:SHL EW DXCM SZSE:300760 XAMS:PHIA ZBH
Traded in Other Exchanges
RSLS:USA
Address
1001 Calle Amanecer, San Clemente, CA, USA, 92673
Website
https://www.reshapelifesciences.com
Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.

Reshape Lifesciences (STU:24O0) Headlines

No Headlines